AbelZeta Pharma
PrivateLast Round
Series A
Sep 30, 2021
Total Funding Raised
$120M
Company Overview
AbelZeta Pharma is a biopharmaceutical company that focuses on developing innovative and proprietary cell-based therapeutic products to treat hematological malignancies, solid tumors, and inflammatory and immunological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AbelZeta Pharma Comps
Public and private peers based on sector, stage, and business model.
AbelZeta Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 30, 2021 |
AbelZeta Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GIC Private Limited | Series A |
| HongShan | Series A |
| AstraZeneca CICC Healthcare Industrial Fund | Series A |
| Yunfeng Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 15, 2024
Monthly visitors grew 33% MoM, reaching 2.4K.
- Oct 30, 2024
Monthly visitors increased 80% MoM.
AbelZeta Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AbelZeta Pharma's valuation, stock price, and market status.
